- Home
- AUTL vs IRMD Comparison
AUTL vs IRMD Comparison
Compare AUTL & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- IRMD
- Stock Information
- Founded
- AUTL 2014
- IRMD 1992
- Country
- AUTL United Kingdom
- IRMD United States
- Employees
- AUTL N/A
- IRMD N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- IRMD Medical/Dental Instruments
- Sector
- AUTL Health Care
- IRMD Health Care
- Exchange
- AUTL Nasdaq
- IRMD Nasdaq
- Market Cap
- AUTL 625.4M
- IRMD 756.5M
- IPO Year
- AUTL 2018
- IRMD 2014
- Fundamental
- Price
- AUTL $2.44
- IRMD $59.21
- Analyst Decision
- AUTL Strong Buy
- IRMD Strong Buy
- Analyst Count
- AUTL 5
- IRMD 1
- Target Price
- AUTL $9.32
- IRMD $72.00
- AVG Volume (30 Days)
- AUTL 1.9M
- IRMD 67.3K
- Earning Date
- AUTL 08-07-2025
- IRMD 07-31-2025
- Dividend Yield
- AUTL N/A
- IRMD 1.15%
- EPS Growth
- AUTL N/A
- IRMD 10.72
- EPS
- AUTL N/A
- IRMD 1.55
- Revenue
- AUTL $9,011,000.00
- IRMD $75,154,639.00
- Revenue This Year
- AUTL $461.76
- IRMD $10.62
- Revenue Next Year
- AUTL $112.66
- IRMD $9.69
- P/E Ratio
- AUTL N/A
- IRMD $38.21
- Revenue Growth
- AUTL N/A
- IRMD 11.04
- 52 Week Low
- AUTL $1.11
- IRMD $42.34
- 52 Week High
- AUTL $5.00
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- AUTL 69.05
- IRMD 51.45
- Support Level
- AUTL $2.24
- IRMD $58.44
- Resistance Level
- AUTL $2.44
- IRMD $62.25
- Average True Range (ATR)
- AUTL 0.12
- IRMD 1.54
- MACD
- AUTL -0.01
- IRMD -0.31
- Stochastic Oscillator
- AUTL 95.96
- IRMD 36.00
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.